Xeroderma pigmentosum C (Q92839): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 07:57, 16 August 2026
Xeroderma pigmentosum complementation group C (XPC) is the most frequent subtype of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers). XPC patients demonstrate typical XP manifestations of the skin (progressive freckling and dryness of skin, skin cancer, ocular malignancies) but generally do not display any acute sunburn reactions. In addition XPC patients do not have any neurological abnormalities.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_149585699 |
||
| English | Xeroderma pigmentosum C |
Xeroderma pigmentosum complementation group C (XPC) is the most frequent subtype of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers). XPC patients demonstrate typical XP manifestations of the skin (progressive freckling and dryness of skin, skin cancer, ocular malignancies) but generally do not display any acute sunburn reactions. In addition XPC patients do not have any neurological abnormalities. |
Statements
CID11:ID_149585699
0 references
dki-india-ID_149585699
0 references
Concluído
0 references
15 August 2026
0 references
